Spots Global Cancer Trial Database for biphenotypic leukemia

Every month we try and update this database with for biphenotypic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Infusion of Allogeneic, 3rd Party CD19-specific T Cells	NCT02274506	Blood And Marro... Leukemia Lymphoma	Cyclophosphamid... Fludarabine T-Cell Infusion	18 Years - 70 Years	M.D. Anderson Cancer Center
Infusion of Allogeneic, 3rd Party CD19-specific T Cells	NCT02274506	Blood And Marro... Leukemia Lymphoma	Cyclophosphamid... Fludarabine T-Cell Infusion	18 Years - 70 Years	M.D. Anderson Cancer Center
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies	NCT02120157	Myeloablative C... HLA-mismatched ... Graft Survival Transplantation...	Cyclophosphamid... TBI Busulfan Unmanipulated B... Tacrolimus Mycophenolate m...	6 Months - 25 Years	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies	NCT02991898	Acute Lymphobla... Burkitt Lymphom... Natural Killer ... Chronic Myeloge... Myelodysplastic... Large-cell Lymp... Chronic Lymphoc... Small Lymphocyt... Marginal Zone B... Follicular Lymp... Lymphoplasmacyt... Mantle-Cell Lym... Prolymphocytic ... Hodgkin Lymphom... Multiple Myelom... Acute Myelogeno... Biphenotypic Le... Undifferentiate...	Infusion of Tre...	18 Years - 75 Years	Masonic Cancer Center, University of Minnesota
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor	NCT01350245	Acute Myeloid L... Myelodysplastic... Biphenotypic Le... Acute Lymphocyt... Chronic Myeloid... Chronic Lymphoc... Plasma Cell Neo... Lymphoma Hodgkin's Disea... Aplastic Anemia	Total Body Irra... Donor Lymphocyt... Cyclophosphamid... Mycophenolate M... Tacrolimus Hematopoietic s...	18 Years -	Thomas Jefferson University
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT	NCT01012492	AML ALL Undifferentiate... Biphenotypic Le... Refractory Anem... Refractory Anem... Refractory Cyto... Ref. Cytopenia ... Refractory Anem... Refractory Anem... Myelodysplastic... MDS Associated ...	Abatacept	12 Years -	Boston Children's Hospital
A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies	NCT01036009	Acute Leukemia Acute Myeloid L... Acute Lymphobla... Biphenotypic Le... Pre-leukemic Sy... Monosomy 7 Bone Marrow Clo... Juvenile Myelom... Myelodysplastic... Chronic Myeloge...	Withdrawal of i...	6 Months - 25 Years	University of California, San Francisco
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT	NCT01012492	AML ALL Undifferentiate... Biphenotypic Le... Refractory Anem... Refractory Anem... Refractory Cyto... Ref. Cytopenia ... Refractory Anem... Refractory Anem... Myelodysplastic... MDS Associated ...	Abatacept	12 Years -	Boston Children's Hospital
Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells	NCT01362452	Leukemia Lymphoma	T-Cell Infusion Cord Blood Infu...	1 Year - 75 Years	M.D. Anderson Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: